Actively Recruiting
Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
Led by University Hospital, Strasbourg, France · Updated on 2024-08-29
154
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Severe visual impairment and blindness in children caused by Rare Eye Diseases (RED) significantly affect their quality of life and psychological well-being. This research aims to understand the real-life impact of these conditions on children and teenagers, focusing on their personal experiences, family roles, and social participation. The study addresses the need for better tools that consider age and cultural differences to measure vision-related quality of life (VR-QoL) accurately and meet regulatory standards. The study uses a mixed methods research approach combining quantitative and qualitative techniques. Quantitative data are collected using validated questionnaires for children and teenagers (FVQ-CYP and VQoL-CYP) and caregiver questionnaires (PEM-CY) about participation and environment. Qualitative data involve semi-structured interviews, focus groups, and field observations to gain deeper insights into the children's daily lives and feelings about medical and social support. Participants will complete self-reported and caregiver questionnaires, take part in interviews and focus groups, and be observed in their living environments. The research will analyze all data to validate the questionnaires and develop a comprehensive VR-QoL tool. The main outcome measured is the real-life impact of severe visual impairment and blindness in children and teenagers over 12 months, providing valuable information for care, therapy development, and social integration. The study is led by University Hospital, Strasbourg.
CONDITIONS
Brief Title
Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 8 to 12 years and teenagers aged 13 to 18 years with various levels of visual impairment
- Visual impairment defined by WHO ICD 10 with best-corrected visual acuity less than or equal to 0.3 decimal or 6/18
- Participants must be able to reliably respond to questions about their visual impairment
- Participants and their caregivers must speak and read the study language
- Consent/assent must be provided
You will not qualify if you...
- Participants unable to respond reliably to questions about their visual impairment, including those with severe intellectual disability
- Visual impairment due to functional or non-ophthalmic causes
- Participants unable to provide consent or assent
- Participants who do not speak or read the study language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) to confirm eligibility
Duration - Cross-sectional assessment with a short-term retest for children and teenagers
Participants complete questionnaires and undergo qualitative assessments to evaluate the impact of visual impairment on daily life.
1 baseline visit and 1 retest visit for children and teenagers
Duration - 12 months
Participants' real-life impact of severe visual impairment or blindness is observed over 12 months.
Periodic assessments may occur depending on individual participation
Trial Site Locations
Total: 1 location
1
Centre de Référence pour les Affections Rares en Génétique Ophtalmologique (CARGO), Hôpitaux Universitaires
Strasbourg, France, 67091
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here